BACKGROUND: The specific cell type in primary lung cancer (LC) has imp
ortant consequences, both for treatment and prognosis. Our objective h
as been to evaluate the degree of accuracy of several preoperative tec
hniques in the LC diagnosis. PATIENTS AND METHODS: We have studied 442
diagnostic techniques realized in 360 patients who underwent thoracot
omy for LC in our hospital (1988-1994). Twelve sputum cytologies, 93 t
ransthoracic neddle biopsies (TNB), 73 bronchial aspirated cytologies,
30 bronchial brushing, 205 bronchial biopsies (BB) and 29 transbronch
ial biopsies were included. In each case the cellular type of LC, obta
ined through these techniques, was compared with the result derived fr
om the study of surgical piece (reference diagnosis). To calculate the
degree of concordance between both diagnoses we used the Kappa coeffi
cient (K). RESULTS: The overall concordance between the cellular type
observed in the different preoperative techniques and the definitive r
esult obtained by thoracotomy was 0.61. The worst test was TNB (K = 0.
41). Sputum cytology and BB presented a good histopathological precisi
on (K = 0.75 and 0.70 respectivelly). The rest of techniques showed mo
derate results. On the different histologies, the best result was obta
ined in squamous carcinoma (K = 0.68) and the worst in undifferentiate
d large cell carcinoma (LCC) (K = 0.39). Small-cell lung cancer only s
howed a moderate concordance (K = 0.58). The coexistence and coinciden
ce of two or more tests with the same cellular type were associated wi
th a higher proportion of accuracy (0.97 vs 0.73; p = 0.00002; odds ra
tio: 12.02). CONCLUSIONS: The preoperative histopathological diagnoses
should be interpreted with caution, especially those obtained by TNB
and those where it is implied the LCC. In these two circunstances and
in cases in which the knowledge of the cellular type have relevance, w
e think that the initial diagnosis should be reinforced with a second
result. The precision of the preoperative diagnoses in small-cell lung
cancer must be reevaluated.